MEDTRONIC IRELAND VALIANT CAPTIVIA - FF; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TR
|
Back to Search Results |
|
Model Number VAMF3434C150TE |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Paralysis (1997); Shock (2072); Vascular Dissection (3160)
|
Event Date 03/20/2024 |
Event Type
Death
|
Manufacturer Narrative
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
A valiant captivia stent graft (vamf3434c150te) was implanted during the endovascular treatment of a pau.The penetrating ulcer was situated 33mm from the left subclavian.It was reported during the index procedure, vamf3434c150te was successfully positioned and ct scan revealed no endoleaks. clinical f eedback indicated that the patient developed hemiplegia 2 days post-surgery.Following symptomatic treatment, a cta re-examination taken 7 days post the index procedure which confirmed the presence of reverse tear type a dissection. considering the patient¿s age, no further treatment was given.The patient suffered sudden shock one day later and despite rescue efforts expired.Per the physician the cause of the type a dissection was device related where the proximal bare stent caused the reverse tear type a dissection.
|
|
Manufacturer Narrative
|
Film evaluation summary: the reported dissection was confirmed on the films received, however the cause of this event could not be fully determined.The reported hemiplegia and patient death could not be assessed.It is possible that the proximal bare stent contributed to the type a dissection as it was observed from the films that the proximal bare stent was adjacent to the dissected area.It is also possible that unknown patient co-morbidities may have been a factor in the occurrence of the retrograde type a dissection.Analysis of the returned films did not reveal any obvious out of specification stent graft integrity issues.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Search Alerts/Recalls
|
|
|